Biotech company nears breakthrough in the resurrection of the extinct Tasmanian Tiger - New York Post

A Dallas-based biotech company has nearly completed its reconstruction of the Tasmanian tiger just two years into its de-extinction project. The last known thylacine, commonly referred to as the Ta…